이달의 증례

HOME

자료실
이달의 증례
Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting for the Treatment of Left Main Coronary Artery Disease
년도 2019년 5월
카테고리 이달의 kcj Hot Article
저자 Sang-Cheol Cho, MD, Duk-Woo Park, MD, PhD and Seung-Jung Park, MD, PhD
소속 Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
첨부파일 1 001.jpg
  • 관리자
  • 등록일 : 2019.05.20
  • Hit 255

Severe stenosis of the left main coronary artery (LMCA) generally occurs as a result of atherosclerosis and compromises the blood supply to a wide area of myocardium, thereby increasing the risk of serious adverse cardiac events. Current revascularization strategies for patients with significant LMCA disease include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), both of which have a range of advantages and disadvantages. In general, PCI is associated with a lower rate of periprocedural adverse events and provides more rapid recovery, while CABG provides more durable revascularization. Most clinical trials comparing PCI and CABG for the treatment of LMCA disease have shown PCI to be non-inferior to CABG with respect to mortality and the serious composite outcome of death, myocardial infarction, or stroke in patients with low-to-intermediate anatomical complexities. Remarkable advancements in PCI standards, including safer and more effective stents, adjunctive intravascular imaging or physiologic evaluation, and antithrombotic treatment, may have contributed to these favorable results. This review provides an update on the current management of LMCA disease with an emphasis on clinical data and academic and clinical knowledge that supports the use of PCI in an increasing proportion of patients with LMCA disease.

 

Keywords:

Coronary artery diseasePercutaneous coronary interventionCoronary artery bypassAngioplasty, balloon, coronaryDrug-eluting stentsTreatment outcome

 

원문보기 : https://www.e-kcj.org/DOIx.php?id=10.4070/kcj.2019.0112

댓글 0